Page 35 - Read Online
P. 35

Raman et al. Plast Aesthet Res 2023;10:6  https://dx.doi.org/10.20517/2347-9264.2022.62  Page 3 of 16

               (3) published before November 12, 2021; (4) involved original research; and (5) included at least one of the
               following: (i) clinical outcomes (limb size differences, infection rate, or reduction in conservative
               treatment); (ii) patient-reported outcomes using validated questionnaires/scales; or (iii) imaging outcomes.
               Exclusion criteria were as follows: (1) any avascularized/non-vascular lymph node transfers; (2) published
               in a language other than English; (3) included study designs with patients receiving only combination
               procedures (i.e., LVA and VLNT); (4) did not include any original, extractable data (i.e., review articles,
               commentaries, letters to the editor); (5) no full-text available; and (6) studies involving non-human subjects
               or cadaveric models.

               Three reviewers (Raman S, Sanka S, Ji J) independently screened investigations based on title/abstracts. Two
               research personnel reviewed each full-text article. A third reviewer was used in each instance where there
               was dissonance of opinion. Data from full-text articles were extracted and stored in Microsoft Excel
               (Version 16.52).


               After full-text articles were identified, duplicate studies which included patients from the same institution
               from the same time period were removed to avoid confounding any meta-analysis. If multiple articles
               included the same group of patients and reported the same clinical outcome variables, the investigation
               reporting the most variety of clinical outcomes or greatest sample size was included in this systematic
               review.

               Data extracted from each article included study-specific information (author, year of publication, country,
               study design, and inclusion/exclusion criteria of patients for the study); clinical outcomes (limb
               circumference or volume differences postoperatively, infection rate reduction, and reduction in need for
               conservative therapy); imaging outcomes; patient sample demographics [age, body mass index (BMI),
               gender, comorbidities, etiology of lymphedema, duration of lymphedema]; number of patients in each
               experimental arm; details of surgical intervention (procedure performed, donor and recipient site); staging
               criteria utilized; method in which clinical outcome variables were obtained including the location in the
               limb for circumference/volume measurements; clinical outcomes reported [limb circumference or volume
               difference, infection rate reduction (annual episodes of infection), and reductions in conservative
               treatment]; PROs for each investigation in which a validated questionnaire was utilized; complications
               related to donor or recipient site; and length of follow-up. An American Society of Plastic Surgeons Level of
                                                    [16]
               Evidence was assigned to each investigation . PROs were recorded for each domain in which a value was
               reported.

               Studies reporting infection rates were reviewed to identify those that presented this information in a
               standard fashion (episodes of infection/year preoperatively and postoperatively) to encourage comparability
               between studies. Due to significant variability in methodology and study design, outcomes related to
               improvement in limb size and reductions in conservative treatment were qualitatively summarized in table
               format. Patients were stratified based on donor and recipient site (upper or lower limb lymphedema) for
               meta-analysis of infection rate reduction and PROs. Continuous variables were summarized with mean and
               standard deviation. Categorical variables were summarized with frequencies or percentages.


               Statistical analysis was performed using GraphPad Prism 9.2.0 (Dotmatics, Boston, MA, USA) with a
               statistical significance set to 0.05. Weighted means and fixed-effects pooled variances were tabulated for
               each variable, and these values were used to perform statistical analyses. To compare continuous variables,
               Kruskall-Wallis or Mann-Whitney tests were performed, as appropriate. Meta-analysis heterogeneity was
                                                          [18]
                                                                           [19]
                                     [17]
               calculated using the meta  and metafor packages  in R version 4.0.3  on the R Studio version 2022.02.3
   30   31   32   33   34   35   36   37   38   39   40